Pharma-Bio Serv (PBSV) Return on Capital Employed (2011 - 2026)
Pharma-Bio Serv (PBSV) posted Return on Capital Employed of 3.46% for Q2 2026, up 44.39% on a QoQ basis from 6.22% in Q1 2026, and up 204.0% year-over-year from 1.14% in Q2 2025.
Pharma-Bio Serv (PBSV) Return on Capital Employed (2011 - 2026) Analysis & Trends
Pharma-Bio Serv's Return on Capital Employed history runs 14 years deep, the most recent figure standing at 3.46% for Q2 2026.
- Quarterly Return on Capital Employed rose 204.0% year-over-year to 3.46% in Q2 2026, while the trailing twelve-month figure through Apr 2026 was 3.46% (up 204.0% YoY) and the FY2025 annual result came in at 4.82%, up 312.0% from the prior year.
- Return on Capital Employed was 3.46% for Q2 2026 at Pharma-Bio Serv, up from 6.22% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 7.64% in Q3 2023 and bottomed at 20.97% in Q3 2022.
- A 5-year average of 4.29% and a median of 5.41% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 2665 bps — and 2023, when it soared 2861 bps.
- Pharma-Bio Serv's Return on Capital Employed stood at 6.39% in 2022, then decreased by 3 bps to 6.23% in 2023, then sank by 243 bps to 8.93% in 2024, then soared by 40 bps to 5.37% in 2025, then soared by 36 bps to 3.46% in 2026.
- Business Quant data shows PBSV's Return on Capital Employed at 3.46% in Q2 2026, 6.22% in Q1 2026, and 5.37% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 32.19 Bn | 24.88 Bn | 662.02 Mn | 13.00% |
| 2 | BrightSpring Health Services | 14.68 Bn | 13.78 Bn | 482.22 Mn | 7.68% |
| 3 | Healthequity | 8.43 Bn | 8.16 Bn | 256.31 Mn | 10.67% |
| 4 | Hinge Health | 5.97 Bn | 5.65 Bn | 154.23 Mn | -163.65% |
| 5 | 10x Genomics | 5.92 Bn | 5.38 Bn | 106.18 Mn | -4.23% |
| 6 | MiniMed | 4.52 Bn | 4.22 Bn | 480.00 Mn | -8.46% |
| 7 | Waystar Holding | 4.46 Bn | 4.40 Bn | 216.84 Mn | 4.73% |
| 8 | Doximity | 3.97 Bn | 3.22 Bn | 125.97 Mn | 21.81% |
| 9 | Privia Health | 3.11 Bn | 2.70 Bn | - | 4.60% |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 | -3.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -3.46% |
| Jan 31, 2026 | -6.22% |
| Oct 31, 2025 | -5.37% |
| Jul 31, 2025 | -5.45% |
| Apr 30, 2025 | -5.50% |
| Jan 31, 2025 | -7.38% |
| Oct 31, 2024 | -8.93% |
| Jul 31, 2024 | -8.05% |
| Apr 30, 2024 | -2.16% |
| Jan 31, 2024 | 2.21% |
| Oct 31, 2023 | 6.23% |
| Jul 31, 2023 | 7.64% |
| Apr 30, 2023 | 6.56% |
| Jan 31, 2023 | 5.79% |
| Oct 31, 2022 | 6.39% |
| Jul 31, 2022 | -20.97% |
| Apr 30, 2022 | -20.08% |
| Jan 31, 2022 | -18.46% |
| Oct 31, 2021 | -16.34% |
| Jul 31, 2021 | 4.23% |